The landscape of diabetes care is undergoing a exciting shift with the introduction of rapidly melting GLP-1 therapies. These novel formulations, designed to instantly dissolve under the sublingually, offer the opportunity for faster absorption and a reduced need for scheduled injections. This strategy could enhance patient compliance and potential